Schain Research is growing and we are very excited to announce that Dr Erwei Zeng and Senior RWE Consultant Robyn Donrovich Thoren have joined our stellar team!
Dr Zeng has a PhD in Epidemiology from Karolinska Institutet. Prior to joining Schain Research, Dr Zeng completed her masters and PhD focusing on population-based oncology research. Her expertise spans over critical components of treatment analysis in RWE including comparative effectiveness, determinants of treatment, and safety.
Robyn has a MSc from Stockholm University in Demography and a BA in Economics from New York University. Bringing over 6 years of industry experience in real-world evidence, Robyn has worked on diverse range of research projects across multiple therapeutic areas including autoimmune, cardiometabolic, oncology, and rare diseases.